Select for export Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0014074 PubMed 21152030 Copy citation Copy BibTeX PLoS ONE 2010-12-01 Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Randomized Controlled Trial More
Select for export Psilocybin slows binocular rivalry switching through serotonin modulation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1167/6.6.43 Copy citation Copy BibTeX Journal of Vision 2010-03-18 O. Carter, John D. Pettigrew, Felix Hasler, Guy Wallis, Franz X. Vollenweider OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1167/5.8.683 Copy citation Copy BibTeX Journal of Vision 2010-03-16 Olivia Carter, David C. Burr, John D. Pettigrew, Franz X. Vollenweider OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX eScholarship (California Digital Library) 2009-12-31 Matthew J. Baggott OpenAlex Published psilocybin AnxietyMechanism of ActionReceptor Pharmacology Other More
Select for export Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.4161/oxim.2.4.9380 PubMed 20716904 Copy citation Copy BibTeX Oxidative Medicine and Cellular Longevity 2009-08-31 Kovacic P, Somanathan R. Europe PMC Published psilocybinpsilocin NeuroplasticityMechanism of ActionReceptor Pharmacology Other More
Select for export Agonist-trafficking and hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/092986709787581851 PubMed 19275609 Copy citation Copy BibTeX Unknown journal 2008-12-31 González-Maeso J, Sealfon SC. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyReview Article Review Article More
Select for export Chemical interactions with pyramidal neurons in layer 5 of the cerebral cortex: control of pain and anxiety. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/092986709789057626 PubMed 19799545 Copy citation Copy BibTeX Unknown journal 2008-12-31 Adams JD. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-008-1129-4 PubMed 18488201 Copy citation Copy BibTeX Psychopharmacology 2008-05-17 Heekeren K, Daumann J, Neukirch A, Stock C, Kawohl W, Norra C Europe PMC Published psilocybin Receptor Pharmacology Clinical Trial More
Select for export Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pbb.2007.09.007 PubMed 17905422 Copy citation Copy BibTeX Unknown journal 2007-09-13 Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC. Europe PMC Published psilocybin Receptor PharmacologyAnimal Study Animal Study More
Select for export Antagonism of phencyclidine-induced stimulus control in the rat by other psychoactive drugs. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pbb.2007.07.007 PubMed 17936884 Copy citation Copy BibTeX Unknown journal 2007-08-14 Winter JC. Europe PMC Published psilocybin Receptor PharmacologyAnimal StudyToxicity Animal Study More
Select for export The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1301324 PubMed 17299516 Copy citation Copy BibTeX Neuropsychopharmacology 2007-02-13 Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessAnimal Study Clinical Trial More
Select for export Effects of psilocybin on time perception and temporal control of behaviour in humans. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Queensland's institutional digital repository (The University of Queensland) 2006-05-18 Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P Europe PMC Published psilocybin Receptor PharmacologyConsciousnessDrug Interactions Other More
Select for export SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/chin.200602219 Copy citation Copy BibTeX ChemInform 2005-12-12 Howard Sard, Govindaraj Kumaran, Cynthia Morency, Bryan L. Roth, Beth Ann Toth, Ping He OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-916185 PubMed 16342002 Copy citation Copy BibTeX Pharmacopsychiatry 2005-10-31 Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M Europe PMC Published psilocybin Receptor PharmacologyHealthy Volunteers Other More
Select for export Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1162/089892905774597191 PubMed 16269092 Copy citation Copy BibTeX Journal of Cognitive Neuroscience 2005-09-30 Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyDrug Interactions Other More
Select for export SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.bmcl.2005.06.104 PubMed 16061378 Copy citation Copy BibTeX Bioorganic & Medicinal Chemistry Letters 2005-09-30 Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P Europe PMC Published psilocybinpsilocin OCDReceptor PharmacologyAnimal Study Animal Study More
Select for export Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-2005-918695 Copy citation Copy BibTeX Pharmacopsychiatry 2005-08-31 Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Other More
Select for export Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1300621 PubMed 15688092 Copy citation Copy BibTeX Unknown journal 2005-05-31 Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D Europe PMC Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psilocybin impairs high-level but not low-level motion perception. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/00001756-200408260-00023 PubMed 15305143 Copy citation Copy BibTeX Unknown journal 2004-07-31 Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX. Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Queensland's institutional digital repository (The University of Queensland) 2003-12-31 O. Carter, David Alais, David C. Burr, Felix Hasler, G. Liu, Guy Wallis OpenAlex Published psilocybin Receptor Pharmacology Other More
